Ryan J Uitti Selected Research

Spinocerebellar Ataxias (Spinocerebellar Ataxia)

1/2021	Frequency of spinocerebellar ataxia mutations in patients with multiple system atrophy.
8/2011	Ataxin-2 repeat-length variation and neurodegeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryan J Uitti Research Topics

Disease

48	Parkinson Disease (Parkinson's Disease) 01/2021 - 07/2002
13	Parkinsonian Disorders (Parkinsonism) 12/2020 - 03/2003
10	Essential Tremor (Essential Tremors) 04/2022 - 09/2009
8	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2020 - 12/2008
7	Tremor (Tremors) 04/2022 - 05/2003
7	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2020 - 04/2006
7	Frontotemporal Dementia (Semantic Dementia) 01/2019 - 04/2006
6	Multiple System Atrophy 01/2021 - 01/2014
6	Dementia (Dementias) 01/2020 - 12/2008
5	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2019 - 02/2007
4	Cognitive Dysfunction 01/2021 - 08/2016
4	Corticobasal Degeneration 12/2020 - 04/2006
4	Synucleinopathies 01/2020 - 01/2014
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2014 - 08/2011
3	Ataxia (Dyssynergia) 01/2021 - 10/2020
2	Lewy Body Disease (Lewy Body Dementia) 01/2022 - 01/2018
2	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 01/2021 - 10/2020
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2021 - 08/2011
2	Disease Susceptibility (Diathesis) 01/2021 - 10/2013
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2018
2	Hallucinations (Hallucination) 01/2018 - 08/2016
2	Mitochondrial Diseases (Mitochondrial Disease) 07/2012 - 03/2012
1	Pick Disease of the Brain (Pick's Disease) 01/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020
1	Orthostatic Hypotension (Postural Hypotension) 10/2019
1	Prostatic Neoplasms (Prostate Cancer) 07/2018
1	Neoplasms (Cancer) 07/2018
1	Lung Neoplasms (Lung Cancer) 07/2018
1	Melanoma (Melanoma, Malignant) 07/2018
1	Breast Neoplasms (Breast Cancer) 07/2018
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2018
1	REM Sleep Behavior Disorder 08/2016
1	Intellectual Disability (Idiocy) 01/2016
1	Hereditary Diffuse Leukoencephalopathy with Spheroids 08/2012
1	Atrophy 08/2012
1	Primary Cervical Dystonia 04/2012
1	Sarcoma (Soft Tissue Sarcoma) 02/2012

Drug/Important Bio-Agent (IBA)

12	SynucleinsIBA 01/2020 - 02/2007
10	Phosphotransferases (Kinase)IBA 01/2021 - 12/2005
10	Leucine (L-Leucine)FDA Link 01/2021 - 12/2005
9	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 12/2020 - 05/2011
7	Levodopa (L Dopa)FDA LinkGeneric 01/2018 - 03/2003
5	Proteins (Proteins, Gene)FDA Link 10/2020 - 03/2013
4	Apolipoproteins E (ApoE)IBA 01/2021 - 12/2017
3	Mitochondrial DNA (mtDNA)IBA 01/2022 - 01/2020
3	polyglutamineIBA 01/2021 - 10/2015
3	alpha-SynucleinIBA 12/2020 - 02/2009
3	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2019 - 12/2008
3	Amyloid (Amyloid Fibrils)IBA 10/2018 - 12/2017
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 05/2007
3	ProgranulinsIBA 12/2008 - 02/2007
3	Dopamine Agonists (Dopamine Agonist)IBA 12/2006 - 07/2002
2	salicylhydroxamic acid (SHAM)IBA 04/2022 - 01/2020
2	Ataxin-3IBA 01/2021 - 10/2020
2	Dopamine (Intropin)FDA LinkGeneric 01/2017 - 01/2016
2	levodopa drug combination carbidopa (Nakom)FDA LinkGeneric 01/2016 - 01/2016
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2014 - 01/2014
2	EnzymesIBA 03/2012 - 11/2011
2	UbiquitinIBA 12/2008 - 02/2007
1	IGF-I-IGFBP-3 complex FDA Link 01/2022
1	TATA-Box Binding Protein (TATA-Binding Protein)IBA 01/2021
1	NucleotidesIBA 01/2021
1	tributyl phosphate (TBP)IBA 01/2021
1	Biological ProductsIBA 10/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Glucosylceramidase (Glucocerebrosidase)IBA 01/2020
1	ethyl 4-azidophenyl-1,4-dithiobutyrimidateIBA 01/2020
1	hydroxide ionIBA 10/2019
1	HLA-DQA2 antigenIBA 01/2019
1	Cholinergic Agents (Cholinergics)IBA 01/2018
1	ApolipoproteinsIBA 01/2018
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2017
1	fluorodopa F 18IBA 01/2017
1	Serotonin (5 Hydroxytryptamine)IBA 01/2017
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2017
1	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 01/2017
1	Glutamic Acid (Glutamate)FDA Link 01/2016
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2016
1	Nuclear Export Signals (Nuclear Export Signal)IBA 01/2014
1	RNA-Binding Protein FUSIBA 01/2014
1	Protons (Proton)IBA 08/2012
1	Macrophage Colony-Stimulating FactorIBA 08/2012
1	5- iodo- 3- ((3,5- dibromo- 4- hydroxyphenyl)methylene)- 2- indolinoneIBA 07/2012
1	UbiquinoneIBA 07/2012
1	Sirolimus (Rapamycin)FDA Link 07/2012
1	angiogeninIBA 05/2012
1	Glutathione Transferase (Glutathione S-Transferase)IBA 04/2012
1	SolutionsIBA 04/2012
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 02/2012
1	sepiapterin reductaseIBA 11/2011
1	sapropterin (tetrahydrobiopterin)FDA Link 11/2011
1	Glutamine (L-Glutamine)FDA Link 08/2011

Therapy/Procedure

9	Deep Brain Stimulation 04/2022 - 04/2007
7	Therapeutics 10/2020 - 03/2003
2	Activities of Daily Living (ADL) 07/2017 - 01/2010
1	Radiotherapy 01/2020
1	Lasers (Laser) 10/2018
1	Palliative Care (Palliative Therapy) 07/2018
1	Drug Therapy (Chemotherapy) 01/2012